Is TB-500 Legal in New York? How to Access It Legally

HealthRX.com

No federal document makes TB-500 clearly legal in New York

Print or save as PDF

See the public record for TB-500

  • What it is / a synthetic 7-amino-acid fragment of thymosin beta-4 [1]
  • FDA approval / none in the US, and no approved product found in Canada, Australia, the UK or several European countries [1]
  • FDA lists / in none of the three categories for state-licensed pharmacies and physicians, and not on the outsourcing-facility list [2][3][4]
  • FDA safety-risk page / nominated-but-withdrawn table, not active category 2 [7]
  • HHS draft policy / TB-500 acetate injection; non-binding [5][6]
  • Sport / prohibited at all times by WADA [8][9]

What TB-500 Is

TB-500 is a synthetic 7-amino-acid, N-acetylated fragment of thymosin beta-4 (residues 17 to 23, about 889 g/mol), not the full 43-amino-acid protein [1]. 'TB-500' is a common name, and FDA found several salts and derivatives sold under it [1]. Human trials of full-length thymosin beta-4 tested a different molecule [10][11].

Where It Stands With FDA

FDA's July 2026 review found no USP or National Formulary monograph for TB-500 and no FDA-approved drug containing it [1]. It appears in none of the three categories on FDA's list for state-licensed pharmacies and physicians (updated 14 May 2026) and is not on FDA's list for outsourcing facilities, so the category 1 policy (generally no action against a compounder that meets the guidance conditions) does not cover it [2][3][4]. FDA found no pharmacy marketing a compounded TB-500 product [1].

On FDA's safety-risk page, TB-500 sits in the 'nominated but withdrawn' table, not the active category 2 table, and removal from category 2 was not a finding that it is safe [7].

The Pharmacy Compounding Advisory Committee voted in favor of listing it on 23 July 2026, against FDA staff's recommendation; TB-500 is not on the list [12][1]. HHS's draft policy (Federal Register document 2026-22192, filed 28 October 2026) covers TB-500 acetate by subcutaneous or intramuscular injection and says HHS 'does not intend to take enforcement action' against a state-licensed pharmacy, federal facility or licensed physician compounding with it when the policy's conditions are met; the notice says it 'does not establish any rights for any person and is not binding on HHS or the public' [5][6].

Does That Make It Legal in New York?

The federal position does not establish that TB-500 can be lawfully compounded or dispensed. New York's own pharmacy and medical practice rules apply separately from the federal position. Compounded drugs are not FDA-approved, and FDA does not review their safety, effectiveness or quality before they reach patients [5].

Questions worth asking

Choose the questions you want to keep

Sport

WADA names 'Thymosin-beta4 and its derivatives e.g. TB-500' in section S2.3 (growth factors and growth factor modulators), prohibited at all times in and out of competition; it is on the 2026 List in force since 1 January 2026 and stays on the 2027 List [8][9].

What Is Known About Safety

FDA found no study in which TB-500 was given to a person, and none of the three papers the nominator cited involved TB-500 in humans [1]. There is no approved dose; the nomination FDA reviewed proposed a 3 mg/mL lyophilized powder for injection, a proposed formulation rather than a recommended dose [1]. FDA's adverse-event database search through 26 March 2025 retrieved no TB-500 reports, and its food and supplement complaint system retrieved two cases about a blended TB-500 and BPC-157 product with no safety assessment [1]. FDA's stated concern for injectable TB-500 is immunogenicity, potentially amplified by peptide aggregation and impurities [1].

Is TB-500 legal in New York?
The federal position does not establish that it can be lawfully compounded or dispensed: TB-500 is not FDA-approved and appears in none of the three categories on FDA's bulks list for state-licensed pharmacies and physicians, nor on its list for outsourcing facilities [1][2][3][4]. New York's own rules apply separately.
Is TB-500 the same as thymosin beta-4?
No. TB-500 is a synthetic 7-amino-acid, N-acetylated fragment (residues 17 to 23) of the 43-amino-acid protein thymosin beta-4, and trials of full-length thymosin beta-4 tested a different molecule [1][10][11].
Did the 2026 advisory vote make TB-500 legal?
No. The Pharmacy Compounding Advisory Committee voted in favor of adding it to the bulks list on 23 July 2026, against FDA staff's recommendation, but that advice is not binding and TB-500 is not on the list [12][1].
Can athletes use TB-500?
WADA names 'Thymosin-beta4 and its derivatives e.g. TB-500' in section S2.3 of its Prohibited List, prohibited at all times, and it appears on both the 2026 and 2027 Lists [8][9].
Show all 12 referencesHide references
  1. U.S. Food and Drug Administration.
  2. U.S. Food and Drug Administration.
  3. U.S. Food and Drug Administration.
  4. Bulk Drug Substances Used in Compounding of the FD&C Act | FDA.
  5. Official web page.
  6. Official web page.
  7. Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks | FDA.
  8. World Anti-Doping Agency.
  9. World Anti-Doping Agency.
  10. Wang X, Liu L, Qi L, Lei C, Li P, Wang Y, et al. A first-in-human, randomized, double-blind, single- and multiple-dose, phase I study of recombinant human thymosin β4 in healthy Chinese volunteers. J Cell Mol Med. 2021;25(17):8222-8228.
  11. Sosne G, Ousler GW. Thymosin beta 4 ophthalmic solution for dry eye: a randomized, placebo-controlled, Phase II clinical trial conducted using the controlled adverse environment (CAE™) model. Clin Ophthalmol. 2015;9:877-84.
  12. U.S. Food and Drug Administration.
Evidence overview for Is TB-500 Legal in New York? How to Access It Legally